Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca M Buffa

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Nature|October 25, 2008
MicroRNA-10b and breast cancer metastasisHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Genome Biology|July 1, 2016
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxiaSyed Haider, Alan McIntyre, Ruud G P M van Stiphout, et al.
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancerCarme Camps, Francesca M Buffa, Stefano Colella, et al.
Pigment Cell & Melanoma Research|June 18, 2019
MITF controls the TCA cycle to modulate the melanoma hypoxia responsePakavarin Louphrasitthiphol, Ioanna Ledaki, Jagat Chauhan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2003
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancerFrancesca M Buffa, Glenn D Flux, Matt J Guy, et al.
Cell Death & Disease|January 11, 2024
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer modelsGonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, et al.
Cancer Research|July 9, 2011
microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancerFrancesca M Buffa, Carme Camps, Laura Winchester, et al.
Nature Protocols|April 12, 2019
Guidelines for using sigQC for systematic evaluation of gene signaturesAndrew Dhawan, Alessandro Barberis, Wei-Chen Cheng, et al.
Iscience|December 4, 2023
A machine learning and directed network optimization approach to uncover <i>TP53</i> regulatory patternsCharalampos P Triantafyllidis, Alessandro Barberis, Fiona Hartley, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Nature|October 25, 2008
MicroRNA-10b and breast cancer metastasisHarriet E Gee, Carme Camps, Francesca M Buffa, et al.
Genome Biology|July 1, 2016
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxiaSyed Haider, Alan McIntyre, Ruud G P M van Stiphout, et al.
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancerCarme Camps, Francesca M Buffa, Stefano Colella, et al.
Pigment Cell & Melanoma Research|June 18, 2019
MITF controls the TCA cycle to modulate the melanoma hypoxia responsePakavarin Louphrasitthiphol, Ioanna Ledaki, Jagat Chauhan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2003
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancerFrancesca M Buffa, Glenn D Flux, Matt J Guy, et al.
Cell Death & Disease|January 11, 2024
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer modelsGonzalo Rodriguez-Berriguete, Rathi Puliyadi, Nicole Machado, et al.
Cancer Research|July 9, 2011
microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancerFrancesca M Buffa, Carme Camps, Laura Winchester, et al.
Nature Protocols|April 12, 2019
Guidelines for using sigQC for systematic evaluation of gene signaturesAndrew Dhawan, Alessandro Barberis, Wei-Chen Cheng, et al.
Iscience|December 4, 2023
A machine learning and directed network optimization approach to uncover <i>TP53</i> regulatory patternsCharalampos P Triantafyllidis, Alessandro Barberis, Fiona Hartley, et al.
Pageof 11